Microarray technology for yeast identification directly from positive blood cultures. A multicenter Italian experience

References

• Martin GS, Mannino DM, Eaton S. Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348: 1546–1554.
   PubMed Web of Science ®Google Scholar
• De Pauw BE. Increasing fungal infections in the intensive care unit. Surg Infect (Larchmt) 2006; 7 (Suppl 2): 93–96.
   PubMedGoogle Scholar
• Darouiche RO. Candida in the ICU. Clin Chest Med 2009; 30: 287–293.
   PubMed Web of Science ®Google Scholar
• Tortorano AM, Biraghi E, Astolfi A, . European Confederation of Medical Mycology (ECMM) prospective survey of candidaemia: report from one Italian region. J Hosp Infect 2002; 51: 297–304.
   PubMed Web of Science ®Google Scholar
• Ahmad S, Khan Z, Mustafa AS, Khan ZU. Seminested PCR for diagnosis of candidemia: comparison with culture, antigen detection, and biochemical methods for species identification. J Clin Microbiol 2002; 40: 2483–2489.
   PubMed Web of Science ®Google Scholar
• Maaroufi Y, De Bruyne JM, Duchateau V, Georgala A, Crokaert F. Early detection and identification of commonly encountered Candida species from simulated blood cultures by using a real-time PCR-based assay. J Mol Diagn 2004; 6: 108–114.
   PubMed Web of Science ®Google Scholar
• Innings A, Ullberg M, Johansson A, . Multiplex real-time PCR targeting the RNAseP RNA gene for detection and identification of Candida species in blood. J Clin Microbiol 2007; 45: 874–880.
   PubMed Web of Science ®Google Scholar
• Metwally L, Hogg G, Coyle PV, . Rapid differentiation between fluconazole-sensitive and -resistant species of Candida directly from positive blood-culture bottles by real-time PCR. J Med Microbiol 2007; 56: 964–970.
   PubMed Web of Science ®Google Scholar
• Dunyach C, Bertout S, Phelipeau C, . Detection and identification of Candida spp. in human serum by LightCycler real-time polymerase chain reaction. Diagn Microbiol Infect Dis 2008; 60: 263–271.
   PubMed Web of Science ®Google Scholar
• Shin JH, Nolte FS, Holloway BP, Morrison CJ. Rapid identification of up to three Candida species in a single reaction tube by a 5′ exonuclease assay using fluorescent DNA probes. J Clin Microbiol 1999; 37: 165–170.
   PubMed Web of Science ®Google Scholar
• Edmond MB, Wallace SE, McClish DK, . Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 1999; 29: 239–244.
   PubMed Web of Science ®Google Scholar
• Leroy O, Gangneux JP, Montravers P, . and AmarCand Study Group. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005–2006). Crit Care Med 2009; 37: 1612–1618.
   PubMed Web of Science ®Google Scholar
• Tortorano AM, Peman J, Bernhardt H, . and ECMM Working Group on Candidaemia. Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur J Clin Microbiol Infect Dis 2004; 23: 317–322.
   PubMed Web of Science ®Google Scholar
• Farina C, Manso E, Andreoni S, . Interlaboratory evaluation of antifungal susceptibilitry testing. New Microbiol 2011; 34: 157–163.
   PubMedGoogle Scholar
• Pfaller MA, Castanheira M, Meser SA, Moet GJ, Jones RN. Variation in Candida spp. distribution and antifungal resistance rates among bloodstream infection isolates by patient age: report from the SENTRY Antimicrobial Surveillance Program (2008–2009). Diagn Microbiol Infect Dis 2010; 68: 278–283.
   PubMed Web of Science ®Google Scholar
• Morrell M, Fraser VJ, Kollef MJ. Delaying empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for mortality. Antimicrob Agents Chemother 2005; 49: 3640–3645.
   PubMed Web of Science ®Google Scholar
• Nguyen MH, Peacock JE Jr, Morris AJ, . The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Am J Med 1996; 100: 617–623.
   PubMed Web of Science ®Google Scholar
• Cuenca-Estrella M, Rodriguez D, Almirante B, . and Barcelona Candidemia Project Study Group. In vitro susceptibilities of bloodstream isolates of Candida species to six antifungal agents: results from a population-based active surveillance programme, Barcelona, Spain, 2002–2003. J Antimicrob Chemother 2005; 55: 194–199.
   PubMed Web of Science ®Google Scholar
• Foster N, Symes C, Barton R, Hobson R. Rapid identification of Candida glabrata in Candida bloodstream infections. J Med Microbiol 2007; 56: 1639–1643.
   PubMed Web of Science ®Google Scholar
• The European Committee on Antimicrobial Susceptibility Testing – EUCAST. Antimicrobial for Candida infections. EUCAST clinical MIC breakpoints. http://www.eucast.org/clinical_breakpoints/EUCAST 2008-07-24 (V 2.0).
   Google Scholar
• Garey KW, Reye M, Pai MP, . Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis 2006; 43: 25–31.
   PubMed Web of Science ®Google Scholar
• Spiess B, Seifarth W, Hummel M, . DNA microarray-based detection and identification of fungal pathogens in clinical samples from neutropenic patients. J Clin Microbiol 2007; 45: 3743–3753.
   PubMed Web of Science ®Google Scholar